Association of amyloid positron emission tomography with changes in diagnosis and patient treatment in an unselected memory clinic cohort: the ABIDE project A de Wilde, WM van der Flier, W Pelkmans, F Bouwman, J Verwer, ... JAMA neurology 75 (9), 1062-1070, 2018 | 129 | 2018 |
Applying the ATN scheme in a memory clinic population: the ABIDE project D Altomare, A de Wilde, R Ossenkoppele, W Pelkmans, F Bouwman, ... Neurology 93 (17), e1635-e1646, 2019 | 70 | 2019 |
Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease W Pelkmans, E Dicks, F Barkhof, H Vrenken, P Scheltens, ... Human brain mapping 40 (13), 3900-3909, 2019 | 52 | 2019 |
Association of CSF, plasma, and imaging markers of neurodegeneration with clinical progression in people with subjective cognitive decline JL Ebenau, W Pelkmans, IMW Verberk, SCJ Verfaillie, KA van den Bosch, ... Neurology 98 (13), e1315-e1326, 2022 | 47 | 2022 |
Development and usability of ADappt: web-based tool to support clinicians, patients, and caregivers in the diagnosis of mild cognitive impairment and Alzheimer disease IS van Maurik, LNC Visser, RE Pel-Littel, MM van Buchem, MD Zwan, ... JMIR formative research 3 (3), e13417, 2019 | 44 | 2019 |
Impact of the FindMyApps program on people with mild cognitive impairment or dementia and their caregivers; an exploratory pilot randomised controlled trial KM Beentjes, DP Neal, YJF Kerkhof, C Broeder, ZDJ Moeridjan, ... Disability and Rehabilitation: Assistive Technology 18 (3), 253-265, 2023 | 25 | 2023 |
Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project A de Wilde, R Ossenkoppele, W Pelkmans, F Bouwman, C Groot, ... Alzheimer's & Dementia 15 (11), 1458-1467, 2019 | 18 | 2019 |
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum W Pelkmans, R Ossenkoppele, E Dicks, O Strandberg, F Barkhof, ... Alzheimer's Research & Therapy 13, 1-11, 2021 | 17 | 2021 |
Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old W Pelkmans, N Legdeur, M Ten Kate, F Barkhof, MM Yaqub, H Holstege, ... Annals of Clinical and Translational Neurology 8 (2), 348-358, 2021 | 12 | 2021 |
Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression W Pelkmans, M Shekari, A Brugulat‐Serrat, G Sánchez‐Benavides, ... Alzheimer's & Dementia 20 (1), 483-493, 2024 | 8 | 2024 |
Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups JJ Van't Hooft, W Pelkmans, J Tomassen, C Smits, N Legdeur, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (4), 314-320, 2023 | 8 | 2023 |
Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline W Pelkmans, EM Vromen, E Dicks, P Scheltens, CE Teunissen, F Barkhof, ... Brain communications 4 (2), fcac026, 2022 | 6 | 2022 |
The impact of amyloid PET disclosure on quality of life in patients with young onset dementia DM van der Doelen, RLH Handels, MD Zwan, SMJ van Kuijk, ... Alzheimer Disease & Associated Disorders 36 (1), 1-6, 2022 | 2 | 2022 |
Development and usability of ADappt: web-based tool to support clinicians, patients, and caregivers in the diagnosis of mild cognitive impairment and Alzheimer disease. JMIR … IS van Maurik, LN Visser, RE Pel-Littel, MM van Buchem, MD Zwan, ... | 2 | |
The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals … I Cumplido-Mayoral, A Brugulat-Serrat, G Sánchez-Benavides, ... The Lancet Healthy Longevity 5 (4), e276-e286, 2024 | 1 | 2024 |
Added diagnostic accuracy after [18F] flutemetamol PET scanning in young patients with dementia in an academic memory clinic setting RLH Handels, MD Zwan, W Pelkmans, GJ Biessels, P van Domburg, ... medRxiv, 2021.11. 30.21266815, 2021 | 1 | 2021 |
Development and usability of ADappt—an online tool to support clinicians, patients and caregivers in the diagnosis of mild cognitive impairment and Alzheimer's disease IS Van Maurik, LNC Visser, R Pel-Littel, MM van Buchem, MD Zwan, ... JMIR Form Res 3, 2019 | 1 | 2019 |
Amyloid-β is associated with thinner cortex in cognitively normal oldest-old individuals W Pelkmans, N Legdeur, M ten Kate, MM Yaqub, BNM Van Berckel, ... Alzheimers & Dementia 15 (7), P1104-P1105, 2019 | 1 | 2019 |
[IC‐P‐005]: CONCORDANCE BETWEEN CEREBROSPINAL FLUID AMYLOID‐β AND [18F]FLORBETABEN PET IN AN UNSELECTED COHORT OF MEMORY … A de Wilde, WM van der Flier, FH Bouwman, R Ossenkoppele, ... Alzheimer's & Dementia 13 (7S_Part_1), P13-P14, 2017 | 1 | 2017 |
Lifetime Stressful Events Associated with Alzheimer's Pathologies, Neuroinflammation and Brain Structure in a Risk Enriched Cohort E Palpatzis, M Akinci, P Aguilar‐Dominguez, M Garcia‐Prat, K Blennow, ... Annals of Neurology, 2024 | | 2024 |